Driscoll Michael Joseph
SEC Form 4 insider trading activity
Driscoll Michael Joseph has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 11, 2026.
On the most recent filing, Driscoll Michael Joseph is listed as Director at Organogenesis Holdings Inc. Inside the rolling window, Driscoll Michael Joseph reported 1 open-market purchase totaling $27K in ORGO and no open-market sales.
Companies traded
Other insiders at ORGO
Insider Buying
$27K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Driscoll Michael Joseph made?
Driscoll Michael Joseph has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Driscoll Michael Joseph trade?
Driscoll Michael Joseph has filed SEC Form 4 disclosures for 1 company, including ORGO.
When was Driscoll Michael Joseph's most recent SEC Form 4 filing?
Driscoll Michael Joseph's most recent SEC Form 4 filing on Tracefour is dated Mar 11, 2026.
What is Driscoll Michael Joseph's total buy and sell value in the current window?
Inside the rolling retention window, Driscoll Michael Joseph bought $27K and sold $0 based on SEC Form 4 filings.
What was Driscoll Michael Joseph's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 ORGO shares on 2026-03-09, worth $27K, per SEC Form 4 filings.